Introduction:
AMAG Pharmaceuticals (AMAG) is a specialty pharmaceuticals company with an emphasis on Women's Health and treatment of Iron Deficiency Anemia. The company's stock has been punished over the past quarter due to the presence of generics taking market share from its key product, Makena. There exists both substantial value and investment risks in the company's product portfolio, but this is made more positive by AMAG having one of the best financial health in the pharmaceuticals sector. In this article, the author shall first; 1) Provide a brief overview of AMAG's key products;